Edinburgh Research Explorer

A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

Research output: Contribution to journalArticle

  • Alistair S Hall
  • Beryl M Jackson
  • Amanda J Farrin
  • Maria Efthymiou
  • Julian H Barth
  • Joanne Copeland
  • Kristian M Bailey
  • Simon P R Romaine
  • Anthony J Balmforth
  • Terry McCormack
  • Andrew Whitehead
  • Marcus D Flather
  • Jane Nixon
  • SPACE ROCKET Trial Group
  • Gordon Murray

Related Edinburgh Organisations

Original languageEnglish
Pages (from-to)712-21
Number of pages10
JournalEuropean journal of preventive cardiology
Volume16
Issue number6
DOIs
Publication statusPublished - 2009

Abstract

We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.

ID: 3336387